Company Overview
Snapshot
Founded in February 2019 by Yuval Yaskil, Shani Eliyahu-Gross, and Amit Har-Lev, polyMERit operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of smart reactive polymers for wound care.
Business overview
polyMERit develops a minimally invasive, self-reactive, multilayered medical device utilizing smart polymers for the treatment of bleeding, post-surgical infections, and seromas. The company employs nano-molecular design to create polymer behaviors and clinical solutions for surgeons across various disciplines. Its medical devices are designed for laparoscopy, endoscopy, and endo-luminal applications, managing surgical wounds and infections through stimuli-response mechanisms. polyMERit operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is polyMERit's core technology?
- polyMERit's core technology involves smart reactive polymers designed into a minimally invasive, self-reactive, multilayered medical device. This technology addresses bleeding, post-surgical infections, and seromas by managing surgical wounds and infections on demand through stimuli-response mechanisms.
- When was polyMERit founded and by whom?
- polyMERit was founded in February 2019 by Yuval Yaskil, Shani Eliyahu-Gross, and Amit Har-Lev.
- What markets does polyMERit serve?
- polyMERit serves the healthcare market, providing solutions for surgeons in multiple disciplines, with applications in laparoscopy, endoscopy, and endo-luminal procedures.
- What is the current product development stage for polyMERit?
- polyMERit's products are currently in the Research & Development (R&D) stage, as of their last update in February 2023.
- What is polyMERit's primary sector?
- polyMERit's primary sector is Health Tech & Life Sciences, with a focus on Medical Devices and Medical Treatment & Therapeutics.